Study of Rituximab in Addition to Glucocorticoid in Pretreated Elderly or Unfit Patients with Chronic B Lymphocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Rituximab (Primary) ; Dexamethasone; Methylprednisolone
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 09 Apr 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 09 Dec 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov.
- 09 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.